Correlation Between Quoin Pharmaceuticals and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Transcode Therapeutics, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Transcode Therapeutics.
Diversification Opportunities for Quoin Pharmaceuticals and Transcode Therapeutics
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Quoin and Transcode is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Quoin Pharmaceuticals and Transcode Therapeutics
Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Transcode Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Quoin Pharmaceuticals Ltd is 1.65 times less risky than Transcode Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Transcode Therapeutics is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 984.00 in Transcode Therapeutics on August 26, 2024 and sell it today you would lose (946.00) from holding Transcode Therapeutics or give up 96.14% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Quoin Pharmaceuticals Ltd vs. Transcode Therapeutics
Performance |
Timeline |
Quoin Pharmaceuticals |
Transcode Therapeutics |
Quoin Pharmaceuticals and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Quoin Pharmaceuticals and Transcode Therapeutics
The main advantage of trading using opposite Quoin Pharmaceuticals and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.Quoin Pharmaceuticals vs. Eliem Therapeutics | Quoin Pharmaceuticals vs. HCW Biologics | Quoin Pharmaceuticals vs. Scpharmaceuticals | Quoin Pharmaceuticals vs. Milestone Pharmaceuticals |
Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |